219 related articles for article (PubMed ID: 30188953)
21. Real-life evaluation of COPD treatment in a Bulgarian population: a 1-year prospective, observational, noninterventional study.
Ivanov Y; Nikolaev I; Nemeth I
Int J Chron Obstruct Pulmon Dis; 2018; 13():653-663. PubMed ID: 29503539
[TBL] [Abstract][Full Text] [Related]
22. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
[TBL] [Abstract][Full Text] [Related]
23. Inhaled short acting beta agonist use in COPD and the risk of acute myocardial infarction.
Suissa S; Assimes T; Ernst P
Thorax; 2003 Jan; 58(1):43-6. PubMed ID: 12511719
[TBL] [Abstract][Full Text] [Related]
24. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
[TBL] [Abstract][Full Text] [Related]
25. Statin use and risk of COPD exacerbation requiring hospitalization.
Wang MT; Lo YW; Tsai CL; Chang LC; Malone DC; Chu CL; Liou JT
Am J Med; 2013 Jul; 126(7):598-606.e2. PubMed ID: 23684060
[TBL] [Abstract][Full Text] [Related]
26. Inhaled beta-2-agonists/muscarinic antagonists and acute myocardial infarction in COPD patients.
Rottenkolber M; Rottenkolber D; Fischer R; Ibáñez L; Fortuny J; Ballarin E; Sabaté M; Ferrer P; Thürmann P; Hasford J; Schmiedl S
Respir Med; 2014 Aug; 108(8):1075-90. PubMed ID: 24950946
[TBL] [Abstract][Full Text] [Related]
27. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
28. Preoperative management using inhalation therapy for pulmonary complications in lung cancer patients with chronic obstructive pulmonary disease.
Takegahara K; Usuda J; Inoue T; Ibi T; Sato A
Gen Thorac Cardiovasc Surg; 2017 Jul; 65(7):388-391. PubMed ID: 28281043
[TBL] [Abstract][Full Text] [Related]
29. Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study.
Raymakers A; Sin DD; Sadatsafavi M; FitzGerald JM; Marra CA; Lynd LD
Respir Res; 2020 May; 21(1):118. PubMed ID: 32429927
[TBL] [Abstract][Full Text] [Related]
30. The impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting β-agonist therapy in COPD.
Short PM; Williamson PA; Elder DHJ; Lipworth SIW; Schembri S; Lipworth BJ
Chest; 2012 Jan; 141(1):81-86. PubMed ID: 21799028
[TBL] [Abstract][Full Text] [Related]
31. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
Hanania NA
Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
[TBL] [Abstract][Full Text] [Related]
32. Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey.
Ding B; Small M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1753-1763. PubMed ID: 28670116
[TBL] [Abstract][Full Text] [Related]
33. Increased risk of chronic obstructive pulmonary disease in patients with rheumatoid arthritis: a population-based cohort study.
Shen TC; Lin CL; Chen CH; Tu CY; Hsia TC; Shih CM; Hsu WH; Sung FC
QJM; 2014 Jul; 107(7):537-43. PubMed ID: 24497528
[TBL] [Abstract][Full Text] [Related]
34. Chronic Obstructive Pulmonary Disease Increases the Risk of Hip Fracture: A Nationwide Population-Based Cohort Study.
Huang SW; Wang WT; Chou LC; Chen HC; Liou TH; Lin HW
Sci Rep; 2016 Mar; 6():23360. PubMed ID: 26987933
[TBL] [Abstract][Full Text] [Related]
35. A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy.
Mapel D; Laliberté F; Roberts MH; Sama SR; Sundaresan D; Pilon D; Lefebvre P; Duh MS; Patel J
Int J Chron Obstruct Pulmon Dis; 2017; 12():1825-1836. PubMed ID: 28684905
[TBL] [Abstract][Full Text] [Related]
36. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
[TBL] [Abstract][Full Text] [Related]
37. Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.
Casas A; Montes de Oca M; Menezes AM; Wehrmeister FC; Lopez Varela MV; Mendoza L; Ramírez L; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2018; 13():1545-1556. PubMed ID: 29785104
[TBL] [Abstract][Full Text] [Related]
38. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
Ohar JA; Donohue JF
Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
[TBL] [Abstract][Full Text] [Related]
39. Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease.
Joos GF
Expert Opin Investig Drugs; 2010 Feb; 19(2):257-64. PubMed ID: 20047505
[TBL] [Abstract][Full Text] [Related]
40. The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study.
Jones R; Martin J; Thomas V; Skinner D; Marshall J; Stagno d'Alcontres M; Price D
Int J Chron Obstruct Pulmon Dis; 2017; 12():2445-2454. PubMed ID: 28860739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
